Clinical Trial Update: Long-term Safety and Efficacy Study of Adalimumab in Pediatric Subjects With Ulcerative Colitis [Phase 3]

View source ↗

Summary

A Phase 3 long-term safety and efficacy study of adalimumab in pediatric patients with ulcerative colitis has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Humira (adalimumab)

Snippet

Sponsor: AbbVie | Conditions: Ulcerative Colitis | Phase 3 | Status: COMPLETED | Results posted: 2025-10-16